Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

The Biotech Growth Trust PLC

Financial Services GB BIOG

1254.0GBX
-10.0(0.79%)

Last update at 2026-06-05T15:35:00Z

Day Range

1236.001262.00
LowHigh

52 Week Range

658.001320.00
LowHigh

Fundamentals

  • Previous Close 1264.00
  • Market Cap257.09M
  • Volume25348
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM-15.17200M
  • Revenue Per Share TTM-0.546
  • Gross Profit TTM -15.17200M
  • Diluted EPS TTM-0.14

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -82.51600M 74.76M -41.24200M -202.27000M 200.56M
Minority interest - - - - -
Net income -82.66100M 74.60M -41.29800M -202.41900M 200.43M
Selling general administrative 3.62M 3.17M 3.52M 3.22M 3.73M
Selling and marketing expenses 0.09M 0.07M 0.07M 0.07M 0.06M
Gross profit -78.80900M 78.00M -37.65400M -209.71100M 222.11M
Reconciled depreciation - - - - -
Ebit - 151.25M -42.03400M -202.44500M 200.38M
Ebitda -82.51600M 74.76M -5.34300M -2.69000M 3.04M
Depreciation and amortization - -76.49500M 36.69M 199.75M -197.34200M
Non operating income net other - - - - -
Operating income -82.51600M 76.50M -36.69100M -199.75500M 197.34M
Other operating expenses 5.03M 3.85M 8.03M 2.85M 21.38M
Interest expense 1.32M 1.11M 0.79M 0.17M 0.18M
Tax provision 0.14M 0.16M 0.06M 0.15M 0.13M
Interest income 0.15M 0.12M 0.01M 0.00300M 0.00000M
Net interest income -1.17800M -0.99200M -0.78100M -0.17200M -0.17900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.14M 0.16M 0.06M 0.15M 0.13M
Total revenue -77.48400M 80.35M -37.65400M -209.71100M 204.35M
Total operating expenses 3.71M 3.24M 3.59M -7.44100M 3.80M
Cost of revenue 1.32M 2.35M - - -17.76000M
Total other income expense net - -1.73600M -4.55100M -2.51500M 3.21M
Discontinued operations - - - - -
Net income from continuing ops -82.66100M 74.60M -41.29800M -202.41900M 200.43M
Net income applicable to common shares - - -41.29800M -202.41900M 200.43M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 226.63M 411.42M 360.51M 427.45M 649.53M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.02M 0.03M - - -
Total liab 5.42M 50.11M 30.22M 33.24M 48.06M
Total stockholder equity 221.21M 361.31M 330.29M 394.21M 601.47M
Deferred long term liab - - - - -
Other current liab - 5.28M 24.01M 32.79M 46.70M
Common stock 6.78M 8.37M 9.68M 10.29M 10.40M
Capital stock 6.78M 8.37M 9.68M 10.29M 10.40M
Retained earnings - -0.96500M -51.65400M -108.58900M 78.26M
Other liab - - - - -
Good will - - - - -
Other assets - 0.03M 427.45M 0.04M 0.04M
Cash 8.45M 2.13M 2.77M 1.50M 1.50M
Cash and equivalents - - - - -
Total current liabilities 0.41M 52.52M 30.22M 33.24M 48.06M
Current deferred revenue - -46.91100M - - -
Net debt -8.45300M 44.95M 17.40M 31.74M 25.28M
Short term debt - 47.08M - - -
Short long term debt - - - - -
Short long term debt total - 47.08M 20.17M 31.74M 26.78M
Other stockholder equity 214.43M 103.48M 41.97M 98.30M -88.65800M
Property plant equipment - - - - -
Total current assets 8.47M 16.67M 3.28M 0.05M 6.26M
Long term investments 218.16M 394.75M 357.23M 427.40M 643.27M
Net tangible assets - - 330.29M 394.21M 601.47M
Short term investments - - - - -
Net receivables - 14.51M 0.49M 4.72M 4.72M
Long term debt - - - - -
Inventory - 0.00000M - - -
Accounts payable 0.41M 0.17M 6.21M 0.45M 1.37M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 250.42M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 10.40M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 217.41M -394.75400M -357.22900M -427.39900M -643.27000M
Deferred long term asset charges - - - - -
Non current assets total 218.16M 394.75M 357.23M 427.40M 643.27M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 115.85M 22.34M 45.69M 14.08M -26.15500M
Change to liabilities - - -0.11600M -18.25500M 18.24M
Total cashflows from investing activities 115.85M 22.34M 45.69M 13.03M -25.54900M
Net borrowings -48.48400M 26.29M -15.33000M 2.62M -2.56400M
Total cash from financing activities -104.29200M -18.74100M -37.03200M -2.39300M 32.73M
Change to operating activities - - - - -
Net income -82.51600M 74.60M -41.24200M -202.27000M 200.56M
Change in cash 6.32M -0.64100M 2.77M -1.50200M 1.50M
Begin period cash flow 2.13M 2.77M 1.50M 1.50M 0.00000M
End period cash flow 8.45M 2.13M 2.77M 1.50M 1.50M
Total cash from operating activities -5.08700M -4.24100M -5.89000M -12.14100M -5.67400M
Issuance of capital stock - - 0.00000M 2.10M 35.54M
Depreciation - - - - -
Other cashflows from investing activities - - - -1.04500M 0.61M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - - - - -
Change to account receivables 0.01000M -0.00600M 0.03M -0.01400M 0.00300M
Sale purchase of stock -54.48300M -43.91300M -20.91000M -6.93300M -106.07900M
Other cashflows from financing activities -1.32500M -1.11500M -16.12200M 2.44M -2.81400M
Change to netincome - - 35.50M 208.55M -224.34200M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.33700M 0.09M -0.08800M -18.26900M 18.24M
Stock based compensation - - - - -
Other non cash items 77.77M -78.93300M 35.44M 208.40M -224.47300M
Free cash flow -5.08700M -4.24100M -5.89000M -12.14100M -5.67400M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BIOG
The Biotech Growth Trust PLC		 -10.0 0.79% 1254.00 - - 4.90 1.00 4.96
FP
Fondul Proprietatea S.A. GDR		 - -% 4.20 - - 19.30 38.04
MNTN
Schiehallion Fund Ltd		 -0.06 2.69% 2.17 0.05 - 4.35 1.25 5.65
BHMU
BH Macro Limited		 0.02 0.45% 4.44 0.09 - 39.01 0.71 6.47
TFG
Tetragon Financial Group Ltd		 -0.05 0.40% 12.40 0.02 7.04 1.16 0.31 2.06 6.56

Reports Covered

Stock Research & News

View All

Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

The Biotech Growth Trust PLC

601 Lexington Avenue, New York, NY, United States, 10022

Key Executives

Name Title Year Born
Mr. Samuel David Isaly Portfolio Mang. 1945
Mr. Samuel David Isaly Portfolio Manager 1945

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions